‘Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study’ by Miao Cai et al. was published in The BMJ at 23:30 hours UK time ...

As GLP-1 adoption accelerates, food and beverage brands face structural shifts in consumption  and strategic decisions on how to communicate them on pack.

A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction – and help people who already have one, a new study shows. Semaglutide (also known as Ozempic) ...

In the GLP-1 weight management market, manufacturers are now launching oral drugs. Novo Nordisk announced the launch of the first GLP-1 drug (Wegovy) in a ...

The study emphasizes the importance of vigilance with diet and exercise, among other things, to reduce CV risk in type 2 diabetes.

Researchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be effective at treating and ...

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn’t use a patch. He ...

The GLP‑1 beverage market is accelerating fast, with brands innovating in hydration, protein, fibre and collagen to meet soaring consumer demand. Discover the growth forecasts, key ingredients, and ...

While McDonald's says it's "pretty protein-forward," the fast food chain is still looking to adapt its menu for GLP-1 users.